Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study
Jianpeng Xiao, Jiya Dai, Jianxiong Hu, Tao Liu, Dexin Gong, Xing Li, Min Kang, Yan Zhou, Yihan Li, Yi Quan, Guanhao He, Ruoxi Zhong, Zhihua Zhu, Qiong Huang, Yingtao Zhang, Jianhua Huang, Qingfeng Du, Yan Li, Tie Song, Wenbiao Hu, Haojie Zhong, Wenjun Ma
Abstract
Background : Nonpharmaceutical interventions (NPIs) are public health measures that aim to suppress the transmission of infectious diseases, including border restrictions, quarantine and isolation, community management, social distancing, face mask usage, and personal hygiene. This research aimed to assess the co-benefits of NPIs against COVID-19 on notifiable infectious diseases (NIDs) in Guangdong Province, China.
Topics & Concepts
Observational studyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMedicineChinaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intervention (counseling)PopulationEnvironmental healthVirologyInfectious disease (medical specialty)GeographyInternal medicineDiseaseNursingOutbreakArchaeologyCOVID-19 Clinical Research StudiesCOVID-19 and Mental HealthSARS-CoV-2 and COVID-19 Research